Blueprint Medicines Corporation (LON:0HOJ)
129.31
+0.02 (0.01%)
At close: Jul 11, 2025
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of 6.20 billion as of July 11, 2025. Its market cap has increased by 17.78% in one year.
Market Cap
6.20B
Enterprise Value
6.06B
Revenue
435.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
129.31
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from 317.21M to 6.20B, an increase of 1,854.78%. That is a compound annual growth rate of 33.82%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 164.77B |
GSK plc | 56.99B |
Haleon | 33.44B |
Smith & Nephew | 10.11B |
ConvaTec Group | 5.33B |
Hikma Pharmaceuticals | 4.40B |
HUTCHMED (China) | 1.98B |
Oxford Nanopore Technologies | 1.47B |